Kolexia
Meynard Guillaume Oncologie médicale
Meynard Guillaume
Oncologie médicale
Hôpital Jean-Minjoz
Besançon, France
70 Activités
104 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Sarcomes Métastase tumorale Récidive tumorale locale Fatigue Tumeurs stromales gastro-intestinales Carcinome épidermoïde de la tête et du cou Troubles de l'endormissement et du maintien du sommeil Cardiotoxicité

Collaborateurs

Voir plus
Mansi Laura
Mansi Laura
Hôpital Jean-Minjoz, Besançon, France
Dobi Erion
Dobi Erion
Hôpital Jean-Minjoz, Besançon, France
Klajer Elodie
Klajer Elodie
Hôpital Jean-Minjoz, Besançon, France
Chaigneau Loic
Chaigneau Loic
Le Mittan Annexe Du Hnfc, Montbéliard, France

Industries

Voir plus
Pfizer
13 collaboration(s)
Dernière en 2023
Lilly
11 collaboration(s)
Dernière en 2023
A+A
10 collaboration(s)
Dernière en 2023
Daiichi Sankyo
7 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
DOMENICA: Randomized Phase III Trial in MMR Deficient Endometrial Cancer Patients Comparing Chemotherapy Alone Versus Dostarlimab in First Line Advanced/Metastatic Setting
Essai Clinique (GSK)   28 février 2024
EXOSARC: Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC)
Essai Clinique (Centre Georges-François Leclerc)   11 décembre 2023
MIRAS: Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   22 septembre 2023
InTTercePT: Treatment With Tucatinib in Addition to Pertuzumab and Trastuzumab in Patients With HER2-positive Metastatic Breast Cancer After Local Therapy of Isolated Brain Progression
Essai Clinique (Seagen)   21 septembre 2023
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten): Randomized, Multicentre, Phase II Study Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After at Least 10 Years of Treatment in Patients With Locally Advanced/Metastatic Gastrointestinal Stromal Tumors (GISTs)
Essai Clinique (Centre Léon-Bérard)   31 août 2023
Prognosis factors for long-term eribulin response in a cohort of patients with HER2-negative metastatic breast cancer.
2023 ASCO Annual Meeting I   31 mai 2023
VolATIL: A Phase II Study Evaluating the Interest to Combine UCPVax a CD4 TH1-inducer Cancer Vaccine and Atezolizumab for the Treatment of Human PapillomaVirus Positive Cancers
Essai Clinique (CHU Besançon)   25 mai 2023
A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study.
BMC cancer   17 mai 2023
BREASTIMMU02: A Multicenter, Randomized, Open-label, Phase II Trial Aiming to Evaluate the Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2 Positive Breast Cancer Patients
Essai Clinique (Amgen)   09 janvier 2023
Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective Analysis.
Oncology   25 octobre 2022